CORT
Corcept Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.80 / 10
Outperform
Analyst sentiment is strongly bullish: two Strong Buy ratings (100%). Fund‑flow score 7.93/10 shows strong inflows from medium to extra‑large investors, though small investors are negative. Overall, capital interest is positive despite modest analyst track record.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-25
InstitutionHC Wainwright & Co.
Times predicted9
Historical Win Rate33.3%
What is the market sentiment for CORT?
- CORT holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.80/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
